Ghost Tree Capital, LLC Aerie Pharmaceuticals Inc Transaction History

Ghost Tree Capital, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 15, 2020	SELL	$11.84 - $25.52 $6.81 Million - $14.7 Million	-575,000 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$17.72 - $25.1 $6.2 Million - $8.79 Million	350,000 Added 155.56%	575,000 $13.9 Million
Q3 2019 Nov 14, 2019	BUY	$18.41 - $28.0 $4.14 Million - $6.3 Million	225,000 New	225,000 $4.33 Million
Q4 2017 Feb 14, 2018	SELL	$50.85 - $65.1 $3.81 Million - $4.88 Million	-75,000 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$48.6 - $60.1 $3.65 Million - $4.51 Million	75,000	75,000 $3.65 Million

2.4M

Ticker AERI
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,390,500
Description
Aerie Pharmaceuticals, Inc., a pharmaceutical company, focuses on the discovery, development, and commercialization of ophthalmic therapies for open-angle glaucoma, dry eye, diabetic macular edema, and wet age-related macular degeneration in the United States. Its products include Rhopressa, a once-daily eye drop to reduce elevated intraocular p...

Get notified when there are updates to the investment portfolio of Ghost Tree Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Ghost Tree Capital, LLC with notifications on news.